background: The aim of this study was to explore the plasticity and transdifferentiation potential of murine spermatogonial stem cells conclusions: Our results indicate that SSCs have the potential to transdifferentiate into hematopoietic cells in vivo.
Introduction
Transdifferentiation has been defined as 'the conversion of a differentiated cell of one developmental commitment into a differentiated cell of another lineage without first reverting to a more primitive stem cell or progenitor, with concomitant loss of tissue-specific markers and function of the original cell type, and acquisition of markers and function of the transdifferentiated cell type' (Wagers and Weissman, 2004) . In human development, transdifferentiation is observed during embryogenesis, growth and regeneration (Thowfeequ et al., 2007) . Understanding transdifferentiation may be helpful for designing new stem cell therapies for various degenerative diseases, e.g. liver and heart diseases, and diabetes (Eberhard and Tosh, 2008) . Other stem cell therapy methods, such as embryonic stem cell (ESC)-or induced pluripotent stem cell (iPS)-based therapy, may have disadvantages because of ethical controversies or oncogenic concerns. Therefore, inducing transdifferentiation of differentiated cells as an alternative therapeutic approach would be more acceptable (Slack, 2007) .
Spermatogonial stem cells (SSCs) originate from primordial germ cells, the latter arising from the proximal epiblast, a region of the early mouse embryo that also contributes to the first blood lineages of the embryonic yolk sac. In adult testis, SSCs reside on the basement membrane of the seminiferous tubules. They have the potential to self-renew and to differentiate in order to produce spermatozoa (Kubota and Brinster, 2006) . Different markers have been successfully used to isolate SSC populations from the testis: CD9, a6 integrin (CD49f), b1 integrin, Thy-1 (CD90) for positive selection, and c-kit (CD117) and MHC-1 (H-2K b in mouse) for negative selection, (Shinohara et al., 1999; Kubota et al., 2003; Kanatsu-Shinohara et al., 2004a; Conrad et al., 2008) . The functionality of murine SSCs can be evaluated by the re-establishment of spermatogenesis after SSC transplantation (SSCT) into infertile mice (Nagano and Brinster, 1998) .
Recently, the pluripotency of SSCs from neonatal and adult mouse testis has been reported by different research teams. Kanatsu-Shinohara et al. (2004b) reported the derivation of pluripotent stem cells from neonatal mouse testis in culture. Subsequently, Guan et al. (2006) showed that SSCs from adult mice testis could generate multipotent cells in vitro which were able to differentiate into different cell types of all three germ layers. Similar phenomena were observed in human SSCs by other research groups (Conrad et al., 2008; Golestaneh et al., 2009; Kossack et al., 2009) . In vivo studies on mice also showed the potential of SSCs to generate tissues of all three germ layers [functional neurons, glia (Glaser et al., 2008; Streckfuss-Bö meke et al., 2009) , cardiomyocytes (Guan et al., 2007) and other somatic cells (Simon et al., 2009) ] without first converting to a more dedifferentiated state.
Hematopoietic stem cells (HSCs) are the primitive cells that have the capability of both self-renewal and differentiation into any of the hematopoietic cell lineages. In mice, hematopoietic cells originate from mesodermal precursors that generate differentiated blood cells during embryogenesis and individual development. In adult bone marrow (BM), the HSC number stays relatively constant in the absence of overt injury or blood loss. Additionally, small populations of HSCs can be detected in mouse peripheral blood (PB) and spleen (SL) (Huang et al., 2007) . To characterize and enrich HSCs, different surface markers are used (Sca-1, CD34, CD45). To further define hematopoiesis and to characterize mature hematopoietic cell lineages, the surface makers CD8 and CD4 for T cells and B220 for B cells are often utilized (Challen et al., 2009) .
Given the similar embryonic origin of SSCs and hematopoietic cells, we hypothesized that SSCs might have the potential to generate hematopoietic cells in vivo. Therefore, we transplanted enriched murine SSCs into the BM of Busulfan-treated recipients. Twelve weeks post-transplantation, phenotype and function were evaluated to characterize the cells in order to define transdifferentiation.
Materials and Methods

Experimental design
Testis cell suspensions isolated from prepubertal green fluorescent protein-positive (GFP + ) male donors were positively enriched for CD49f expression by magnetic activated cell sorting (MACS) and injected into the testis of Busulfan-treated GFP -mice. Hematopoietic cells may contaminate the cell suspension after MACS sorting, but only SSCs will colonize the basement membrane; all other cells (including hematopoietic cells) will have disappeared from the seminferous tubules at the time of evaluation (Van Saen et al., 2009a) . Sixteen weeks after SSCT, GFP
+-
CD49f
+ H-2K b2 cells sorted by MACS and fluorescence-activated cell sorting (FACS) were transplanted into the BM of GFP 2 female recipients.
Recipients injected with GFP + BM cells from male donors or Dulbecco's modified Eagle's medium (DMEM) served as positive and negative controls, respectively. Twelve weeks later, the recipients were sacrificed and their BM, PB and SL cells were evaluated by various methods to define transdifferentiation (Fig. 1 ).
Isolation and purification of SSCs
The mice used in these experiments were bred in the animal centre of the Brussels Free University according to the following breeding model: male C57BL/6J inbred (IffaCredo, Brussels, Belgium) × female SV/129 inbred GFP + (gift from Whitehead Institute for Biomedical Research, Cambridge, MA, USA). The GFP is under the control of the b-actin promoter and is expressed in all cell types. The SSC isolation was performed as described before (Van Saen et al., 2009b) . Male GFP + F1 hybrids, aged 7 -10 days, were used as donors (n ¼ 12). Male GFP 2 F1 hybrids from the same breeding model were used as recipients (n ¼ 12). The recipient mice were sterilized with a sublethal intraperitoneal injection of the gonadotoxic chemotherapeutic agent Busulfan (40 mg/kg; 02154906; MP Biomedicals Inc., Elsene, Belgium) 6 -8 weeks prior to the transplantation. At 2 and 4 weeks following Busulfan injection, these mice were given a subcutaneous injection of the GnRH-agonist Decapeptyl w (0.1 mg; 4.26 mg/kg; Ipsen, Boulogne Billancourt, France). This GnRH agonist will suppress the intratesticular testosterone production and will therefore improve recolonization efficiency in mice and rats after SSCT (Dobrinski et al., 2001) .
Transplantation of SSCs was performed as described before (Goossens et al., 2003) . Briefly, after removing the tunica, single cells were harvested by a two-step enzymatic digestion. During the first step, the tissue was placed in Hank's buffered salt solution (HBSS) containing 300 mg/ml DNase (DN25; Sigma-Aldrich, Bornem, Belgium) and 1 mg/ml collagenase IV (C5138; Sigma-Aldrich) for 15 min at 378C. The tissue was transferred to HBSS containing 2.5 mg/ml trypsin (T-4665; Sigma-Aldrich) and 0.38 mg/ml EDTA (E-6511; Sigma-Aldrich) for 5 min at 378C. Trypsin was inactive with HBSS containing 5% fetal bovine serum (FBS; 10439-016; GIBCO Invitrogen, Merelbeke, Belgium).
The final cell pellet was resuspended in DMEM/F12(31330-038; GIBCO Invitrogen) containing 10% FBS and 10% penicillin/streptomycin (15070-063; GIBCO Invitrogen). The cell suspension was enriched for CD49f
+ cells by MACS using a MiniMACS Separation Unit w (130-042-102; Miltenyi Biotic, Bergisch-Gladbach, Germany), as described in the manufacturer's protocol using a R-Phycoerythrin (R-PE)-conjugated rat anti-CD49f monoclonal antibody (555736; PharMingen, Erembodegem, Belgium) and anti-PE Microbeads (130-048-801, Miltenyi Biotec). Viability was evaluated by trypan blue staining. The cell suspension was kept at 48C prior to transplantation. Male GFP 2 recipients were anesthetized using a mixture of ketamine (0.1 mg/ml, 134c6, CEVA Sante Animale, Brussel, Belgium) and Medetor (0.75 mg/ml, 171007, Virbac Suisse SA, Glattbrugg, Switzerland) given at 75 ml/10 g body weight. After incision of the lower abdomen and exposure of the testis, a glass needle (inner diameter tip of 50 mm) was inserted into the efferent duct, and donor cells were injected into the rete testes using a FemotoJet semi-automatic microinjector (Brinkmann Instruments Inc., Westbury, NY, USA). Approximately 10 ml of the cell suspension containing an average of 7.2 × 10 5 cells with a viability of 92% was injected via the efferent duct into the rete of each recipient testis. At 16 weeks after SSCT, recipients were sacrificed and their testes were removed. Single cells were obtained by two-step enzymatic digestion. The isolated cell suspensions were incubated with an R-PE-conjugated rat anti-CD49f monoclonal antibody at 20 ml per 10 6 cells for 20 min at 48C in the dark and washed three times with excess phosphate-buffered saline (PBS). In a second step, the cells were identically treated with a PerCP-conjugated mouse anti-H-2K b monoclonal antibody (553569; PharMingen) at 2 ml per 10 6 cells. In a final labeling step, 80 ml of MACS buffer
[PBS supplemented with 0.5% bovine serum albumin (BSA) and 2 mM EDTA] per 10 7 cells and 20 ml of anti-PE MACS Microbeads (130-048-801; Miltenyi Biotic) per 10 7 cells were added to the cell pellet. After mixing, the cells were incubated in the dark for 15 min at 48C. The cells were washed with excess MACS buffer and resuspended in 500 ml of buffer per 10 7 cells.
As a first strategy for enrichment of the suspensions for CD49f + cells, MACS was performed as described before. The positive selected cells were finally suspended in 1 ml of MACS buffer per 2 × 10 6 total cells.
FACS was performed with a FACS Vantage Flow Cytometer (BD Biosciences, Erembodegem, Belgium). Three parameters were used to select the cells: the sorted cells had to be CD49f + , GFP + and H-2K b2 .
The sorted cells were collected into polypropylene 5-ml tubes (352063; BD Biosciences) containing 1.5 ml of DMEM supplemented with 10% FBS and 10% penicillin/streptomycin. Data for at least 20 000 events were recorded with the software program Cell Quest version 3.3 (BD Biosciences). To exclude non-specific binding of the antibodies, samples of the suspensions were also labeled with isotype controls. The FACS analysis results were corrected for these isotype controls.
Transplantation of SSCs to the BM of GFP 2 female mice cells were resuspended in transplantation medium (DMEM + 10% FBS). Intra-BM transplantation (IBMT) was carried out as described by Kushida et al. (2001) : a 26-gauge needle was inserted into the joint surface of the tibia through the patellar tendon and further into the BM cavity. Using a microsyringe (1 ml, BD Biosciences), the GFP Busulfan-treated recipients (1 × 10 5 in 10 ml of DMEM + 10% FBS per recipient, n ¼ 12).
Characterization of transplanted cells
Twelve weeks after IBMT, the BM, PB and SL cells were isolated from the intra-IBM transplanted mice and DMEM controls. Bone marrow cells were isolated as described above. Peripheral blood was collected from the tail vein of anesthetized mice. Spleen cells were mechanically dissociated and filtered through a 40-mm nylon mesh to obtain a single cell suspension. 
GFP staining
GFP staining was employed to detect donor-derived cells from the BM, PB and SL cells isolated from the recipients. The cytospin slides were rinsed three times for 2 min in a PBS-Tween (0.2%, 822184; Merck, Darmstadt, Germany) solution. Slides were incubated with 10% normal goat serum for 30 min at room temperature to prevent non-specific binding. The slides were incubated overnight at 48C with anti-GFP antibody (1/100, mouse monoclonal IgG 2a , sc-9996, Santa Cruz Biotechnology, CA, USA). The next day, after three washes in PBS for 2 min, the slides were incubated for 1 h with an anti-mouse IgG secondary antibody (K4000, Envision system; DAKO, Leuven, Belgium) labeled with horseradish peroxidase. After three washes in PBS, immunoreactivity was visualized with a DAB solution provided in the kit (K4000, Envision system; DAKO). Slides were counterstained with hematoxylin and evaluated by light microscopy.
Immunofluorescent double staining
To assess the presence of hematopoietic and donor-derived markers, immunofluorescent double staining for GFP, combined with one of the hematopotiec stem cell makers Sca-1 (1/100, rat anti-mouse, 557403, BD Pharmingen), CD34 (1/100, rat anti-mouse, 553731, BD Pharmingen), CD45 (1/100, rat anti-mouse, 550539, BD Pharmingen) or the hematopoietic cell lineage markers CD8 (1/100, rat anti-mouse, 550281, BD Pharmingen) and CD4 (1/100, rat anti-mouse, 550278, BD Pharmingen), was performed. After two washes in PBS -Tween, slides were incubated with 10% normal goat serum for 30 min. Then, a mixture of two primary antibodies (mouse and rat original) was added and the slides were incubated at 48C overnight. The next day, after three washes in PBS-Tween (0.2%) for 2 min, the mixture of two fluorescent conjugated secondary antibodies [Alexa488-conjugated goat anti-mouse IgG (1/100, rat anti-mouse, 550281, BD Pharmingen) and Alexa633-conjugated goat anti-rat IgG (1/ 250, A-21094, Invitrogen, diluted in PBS)] was added and incubated for 2 h in the dark at 48C. After three washes in PBS -Tween for 2 min, the slides were counterstained, mounted with Prolong Gold antifade reagent with 4,6-diamidino-2-phenylindole (DAPI) (548811, Invitrogen) and left for 10 min in the dark at room temperature, before examination by confocal microscopy (FluoView FV300, Olympus, Hamburg, Germany). ) in 9 ml of hybridization buffer was applied on a cover slip. Slides were sealed using rubber cement, denaturized at 758C for 5 min, and hybridized overnight at 378C in a humidified container. After washing, the slides were counterstained, mounted with Prolong Gold antifade reagent with DAPI (548811, Invitrogen) and left for 10 min in the dark at room temperature, before examination by fluorescence microscopy (Zeiss Axioplan2, Carl Zeiss, Brussels, Belgium).
Combined staining for immunofluorescence and FISH
After cytospin, the slides of recipients' BM cells were treated with 75 mM CaCl 2 for 5 min at 378C then fixed in methanol -acetic acid (3:1) for 5 min at 48C and incubated in denaturation solution (70% formamide, 2× saline sodium citrate, pH 7.4) for 5 min at 738C. In a next step, the slides were dehydrated in 70, 85 and 100% ethanol for 1 min each. The probe (FISH detector, Cy3 labeled) was denaturized at 758C for 5 min and warmed on a 508C heated stage. On each slide, 10 ml of probe was applied before incubation for 4 h at 428C.
After hybridization, slides were washed in 0.4× SSC (pH 7.0) containing 0.3% NP-40 (9036-19-5; Sigma-Aldrich) for 2 min at 738C, and then washed in 2× SSC -0.1% NP-40 (pH 7.2) for 1 min at room temperature. After two washes in PBS for 5 min, the slides were incubated for 1 h at 378C with an anti-CD45 antibody (1/100, rat anti-mouse IgG, 550539, BD PharMingen), washed three times in PBS and incubated for 1 h at room temperature with the secondary antibody (1/250, Alexa633 labeled goat anti-rat IgG, A-21094, Invitrogen) and the FISH detector (Cy3 labeled, 1/500). After three washes in PBS, the slides were counterstained and mounted with Prolong Gold antifade reagent with DAPI (548811, Invitrogen) and left for 10 min in the dark at room temperature, before examination by confocal microscopy.
SSCT evaluation
The testes from the recipients that had undergone SSCT were removed 16 weeks after transplantation. Donor-derived spermatogenesis was examined under UV light and by GFP staining.
Colony-forming units assay
Myeloid progenitors were identified by in vitro colony-forming assays. Briefly, nucleated BM cells or isolated testis cells were plated in 35-mm dishes (150318; Nunc, Copenhagen, Denmark) at 100 000 cells/plate in a commercial medium (Methocult w GF H4534; Stem Cell Technologies, Grenoble, France) containing methylcellulose in Iscove's modified Dulbecco medium, FBS, BSA, 2-mercaptoethanol, L-glutamine, stem cell factor, granulocyte -macrophage colony-stimulating factor and interleukin-3. Cultures were incubated for 14 days at 378C and 5% CO 2 in a humidified atmosphere. Cultures were scored at 14 days with an inverted microscope (IX51, Olympus, Hamburg, Germany) using standard criteria. Data are shown as mean values of colony numbers observed in culture dishes from three different animals.
IBMT
Sorted GFP
b+ cells were directly injected into the BM cavity of Busulfan-treated female GFP 2 mice (5 × 10 5 cells per mice) as described. Hematopoietic characterization and function of transplanted cells were evaluated 12 weeks after transplantation by FACS and IHC as described above.
Statistical analysis
The independent-samples t-test was used to determine a statistical significance (SPSS Statistics 17.0.) A P-value , 0.05 was considered significant.
Results
Survival of donor-derived cells in BM, PB and SL
Twelve weeks after IBMT, female recipients' BM, PB and SL cells were isolated and evaluated by FACS, IHC and FISH. FACS showed that on average 1.8% BM cells, 3.3% blood cells and 0.2% SL cells of testis-to-BM transplanted mice were GFP + . In the BM-to-BM transplantation controls, an average of 7.2% BM cells, 3.8% blood cells and 0.2% SL cells were GFP + . The number of GFP + cells in the DMEM-injected control group was 0.2% in BM, 0.1% in blood and 0.1% in SL ( Fig. 2A and B ). There were significant differences in BM, PB and SL cell GFP positivity between the testis-to-BM transplanted group and the DMEM-injected control group (BM 1.8 + 0.7 versus 0.2 + 0.1% P , 0.05; PB 3.3 + 1.1 versus 0.1 + 0.1%, P , 0.05; SL 0.2 + 0.1 versus 0.1 + 0.1% P , 0.05). There were also significant differences in BM cell GFP positivity between the testis-to-BM transplanted group and the BM-to-BM transplantation controls (BM 1.8 + 0.7 versus 7.2 + 1.8% P , 0.05), but no significant differences in PB and SL GFP positivity (PB 3.3 + 1.1 versus 3.8 + 1.1%; SL 0.2 + 0.1 versus 0.2 + 0.3%). GFP + cells also could be detected by immunostaining in BM, PB and SL cells of BM-to-BM transplantation recipients and testis-to-BM transplanted recipients, but not in DMEM-injected control recipients (Fig. 2C) . were observed in the BM, blood or SL from DMEM-to-BM transplanted control mice (Fig. 2D) .
To indicate that the transplanted cells were functional SSCs, GFP
+-
CD49f
+ H-2K b2 cells were transplanted into the testes of Busulfantreated recipients. Sixteen weeks after SSCT, GFP + cells were detected in seminiferous tubules in the testis-to-testis transplanted mice, both under UV light and by GFP staining. Cross-sections with complete GFP + -cell derived spermatogenesis were observed, indicating the SSC function of transplanted cells (Fig. 3) .
Donor-derived cells express surface markers for HSCs in vivo
To define transdifferentiation, different methods were employed to detect markers of HSCs. GFP + Sca-1 + H-2K b+ cells were sorted from the BM, PB and SL of testis-to-BM transplanted recipients (Fig. 4A) . In the BM of testis-to-BM recipients, 1.2% of total BM in the DMEM control group. Double fluorescent immunostaining confirmed the co-expression of GFP with the HSC markers Sca-1, CD45 and CD34 and hematopoietic cell lineage marker CD8 in BM cells from testis-to-BM transplanted mice (Fig. 4B) . The hematopoietic marker CD45 was also expressed by Y chr + BM cells of testis-to-BM transplanted mice, indicating that these donor-derived cells obtained the morphological characteristics of HSCs.
Donor-derived cells adopt hematopoietic cell function in vitro and in vivo
In each dish, 1 × 10 5 nucleated cells were plated for the colonyforming units (CFU) assays. Two weeks after culture, colonies grew (1) BM-to-BM transplantation (BM-BM, BM 7.2% PB 3.8% SL 0.2%); (2) testis-to-BM transplantation (T-BM, BM 1.8% PB 3.3% SL 0.2%); (3) DMEM control (BM 0.2% 0.1% SL 0.1%); Significant differences were found in BM and PB and but not in SL cell GFP positivity between the testis-to-BM transplanted group and the DMEM-injected control group. Significant differences were also found in BM cell GFP positivity between the testis-to-BM transplanted group and the BM-to-BM transplanted controls. in the dishes: 19 units/dish in the BM-to-BM transplanted group, 14 units/dish in the testis-to-BM transplanted group, 49 units/dish in BM cell control dishes, and no colonies were found in testis cell control dishes (Fig. 4C) .
To evaluate the hematopoietic functionality in vivo, sorted GFP
b+ cells were transplanted into the BM of female GFP 2 recipients. FACS showed that 6.3% of BM cells, 2.4% of PB cells and 0.1 % of SL cells were GFP + (Fig. 4D ). There were no significant differences in GFP positivity of recipients' BM cells after transplantation of GFP + BM cells or GFP + Sca-1 + H-2K b+ testis cells (6.3 + 1.0 versus 7.2 + 1.8%). GFP + cells were also detected by IHC in BM, PB and SL of transplanted mice (Fig. 4E ).
Discussion
The term 'transdifferentiation' is often used to denote the plasticity of stem cell potential. For example, stem cells that normally generate blood would be considered to undergo transdifferentiation if they produced neurons.
In the last few years, several studies have reported on the generation of iPS cells derived from terminally differentiated somatic cells via genetic manipulations and growth factor treatment (Yamanaka, 2007) . This alteration of cell fate has been termed 'reprogramming'. Some researchers believe that reprogramming is a possible mechanism for transdifferentiation (Baeyens and Bouwens, 2008; Eberhard and Tosh, 2008) . Kanatsu-Shinohara et al. (2008) suggested that SSCs might dedifferentiate to pluripotency before differentiating into another tissue. Izadyar et al. (2008) put forward the idea that a subpopulation of pluripotent Pou5f1 + /C-kit + SSCs, different from the Pou5f1 + /C-kit 2 SSCs committed to the germ line, are transdifferentiating when exposed to a different micro-environment. In our research, the SSCs which were transplanted into the BM of recipients may undergo a similar procedure under the 'pressure' of BM circumstances and may have been induced into 'BM-like cells' by paracrine factors secreted by BM cells.
Compared with the generation of differentiated cells or tissues from allogeneic ESCs, transdifferentiation from adult stem cells could be a more feasible and easier method. Moreover, compared with ESCbased research, there are fewer ethical constraints. Recently, different researchers have revealed the pluripotency of SSCs from neonatal and adult testis (Kanatsu-Shinohara et al., 2004b; Guan et al., 2006; Conrad et al., 2008; Golestaneh et al., 2009; Kossack et al., 2009 However, more Y chr-positive cells (6.0%) than GFP-positive cells (1.8%) were found in the BM of recipient mice. This can be explained by the fact that GFP positivity depends on the amount of GFP protein in the examined cells. In our experiment, the cells could not be fixed directly after isolation, because cells had to be alive for the transplantation. After isolation, MACS had to be performed before FACS staining, which in total takes 3-4 h. Although we have worked on ice to protect the cells from degradation, it might have been possible that some of the cell membranes were broken and GFP protein leaked out. A GFP positive control was always included in FACS analyses but we could never reach 100% positivity. On the other hand, the nucleus always remained in the cells so that the Y chr could be detected by FISH. This may indicate that the FACS results could be underestimated and that more donor-derived cells are present in BM and blood from the recipient mice. We have shown that it is not necessary to produce ESC-like cells in vitro prior to differentiation to another cell type. SSCs themselves are able to transdifferentiate when placed in a suitable niche. Our results therefore indicate the clinical potential of SSCs for future stemcell-based therapies.
Since blood vessels are also present in the mouse testis, the risk exists that HSCs contaminating the cell suspension obtained after digestion contributed to the regeneration of BM cells in the recipients. In order to avoid this contamination, we employed two different methods. Firstly, after enrichment by MACS for CD49f, donor SSCs were transplanted into the testes of Busulfan-treated GFP 2 male mice. Based on previous research, HSCs cannot survive in the seminiferous tubules for over 12 weeks (Lassalle et al., 2008; Van Saen et al., 2009a) . As a consequence, HSCs are not present in the GFP + cells isolated from our GFP 2 recipients' testes. Secondly, we used FACS to purify the cell suspension of recipient testes. Three markers were used to separate the cells: GFP + for donor-derived cells, CD49f + for SSCs and H-2K b2 for non-somatic cells (germ cells are nonsomatic cells; HSCs are somatic cells and will not be selected by FACS). Using these two methods, the risk of HSC contamination in our experiments is virtually non-existent. The reported results on stem cell plasticity can be questioned because adult progenitors may undergo cell fusion. Cell fusion, however, is a very rare phenomenon (,0.1% of the cells) (Thowfeequ et al., 2007) . In our experiments, we used FISH for the Y chromosome and IHC for GFP to confirm the donor origin of transdifferentiated cells. FACS results showed that the percentage of positive cells was higher (1.81% in BM; 3.34% in blood) than the natural appearance of cell fusion. Therefore, we have strong indications that our SSCs transdifferentiated into hematopoietic cells.
Our results confirm the plasticity of mouse SSCs and their potential for stem-cell-based therapies in the future. Although we used mouse SSCs in our experiment, the question remains of whether human SSCs will show a similar behavior in vivo. Thus apart from further research on the possible mechanisms of transdifferentiation, subsequent studies need to be done to investigate the clinical potential of human SSCs.
